For AD, research has revealed significant cellular heterogeneity in the brain, identifying key genes such as APOE, CLU, SREBF1, and transcription factors like ZEB1 and MAFB that are implicated in disease pathogenesis, particularly in oligodendrocytes and glial cells. This evidence concerns the gene MAFB and Alzheimer disease.